Waning immunity of one-dose measles-mumps-rubella vaccine to mumps in children from kindergarten to early school age: a prospective study

References

• Levine DA. Vaccine-preventable diseases in pediatric patients: a review of measles, mumps, rubella, and varicella. Pediatr Emerg Med Pract. 2016;13(12):1–20.
   PubMedGoogle Scholar
• WHO. Mumps vaccines WHO position paper – 2007 Weekly epidemiological record. [cited 2017 Jul]. Available from: http://www.who.int/wer/2007/wer8207.pdf?ua=1.
   Google Scholar
• Vygen S, Fischer A, Meurice L, et al. Waning immunity against mumps in vaccinated young adults, France 2013. Euro Surveill. 2016;21(10):30156.
   PubMedGoogle Scholar
• van der Maas NA, Woudenberg T, Hahne SJ, et al. Tolerability of early measles-mumps-rubella vaccination in infants aged 6-14 months during a measles outbreak in the Netherlands in 2013-2014. J Infect Dis. 2016;213(9):1466–1471.
   PubMed Web of Science ®Google Scholar
• Barskey AE, Schulte C, Rosen JB, et al. Mumps outbreak in orthodox jewish communities in the United States. N Engl J Med. 2012;367(18):1704–1713.
   PubMed Web of Science ®Google Scholar
• Woudenberg T, van der Maas NAT, Knol MJ, et al. Effectiveness of early measles, mumps, and rubella vaccination among 6-14-month-old infants during an epidemic in the Netherlands: an observational cohort study. J Infect Dis. 2017;215(8):1181–1187.
   PubMed Web of Science ®Google Scholar
• Leuridan E, Maertens K, Wautier M, et al. Susceptibility to measles, mumps, and rubella in 5-year-old children in Flanders, Belgium. Eur J Pediatr. 2015;174(7):925–932.
   PubMed Web of Science ®Google Scholar
• Hamami D, Cameron R, Pollock KG, et al. Waning immunity is associated with periodic large outbreaks of mumps: a mathematical modeling study of scottish data. Front Physiol. 2017;8(2):233.
   PubMedGoogle Scholar
• Cui A, Zhu Z, Hu Y, et al. Mumps epidemiology and mumps virus genotypes circulating in mainland China during 2013-2015. PloS One. 2017;12(1):e0169561.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hu Y, Deng X, et al. Seroepidemiology of mumps in the general population of Jiangsu province, China after introduction of a one-dose measles-mumps-rubella vaccine. Sci Rep. 2015;5(4):14660.
   PubMedGoogle Scholar
• Kaaijk P, Van Der Zeijst B, Boog M, et al. Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype. Euro Surveill. 2008;13:26.
   Google Scholar
• Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature. 1985;318(6044):323–329.
   PubMed Web of Science ®Google Scholar
• Kenny L, O’Kelly E, Connell J, et al. Mumps outbreaks in a highly vaccinated population: investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus. J Clin Virol. 2016;74(6):8–12.
   PubMedGoogle Scholar
• Patel LN, Arciuolo RJ, Fu J, et al. Mumps outbreak among a highly vaccinated university community-New York City, january-april 2014. Clin Infect Dis. 2017;64(4):408–412.
   PubMed Web of Science ®Google Scholar
• Nedeljkovic J, Kovacevic-Jovanovic V, Milosevic V, et al. A mumps outbreak in vojvodina, serbia, in 2012 underlines the need for additional vaccination opportunities for young adults. PloS One. 2015;10(10):e0139815.
   PubMed Web of Science ®Google Scholar
• ECfDPa. Recommended immunisations for mumps: European Centre for Disease Prevention and Control). 2017. [cited 2017 Jul 1]. Available from: http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx.
   Google Scholar
• Carazo Perez S, De Serres G, Bureau A, et al. Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose. Clin Infect Dis. 2017. DOI:10.1093/cid/cix510
   PubMed Web of Science ®Google Scholar
• Gu XX, Plotkin SA, Edwards KM, et al. Waning immunity and microbial vaccines - workshop of the national institute of allergy and infectious diseases. Clin Vaccine Immunol. 2017. DOI:10.1128/cvi.00034-17
   Web of Science ®Google Scholar
• Gouma S, Sane J, Gijselaar D, et al. Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009-2012). J Gen Virol. 2014;95(Pt 5):1074–1082.
   PubMedGoogle Scholar
• Wang H, Hu Y, Zhang G, et al. Meta-analysis of vaccine effectiveness of mumps-containing vaccine under different immunization strategies in China. Vaccine. 2014;32(37):4806–4812.
   PubMed Web of Science ®Google Scholar
• Gouma S, Ten Hulscher HI, Schurink-van ‘t Klooster TM, et al. Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection. Vaccine. 2016;34(35):4166–4171.
   PubMed Web of Science ®Google Scholar
• Hukic M, Hajdarpasic A, Ravlija J, et al. Mumps outbreak in the Federation of Bosnia and Herzegovina with large cohorts of susceptibles and genetically diverse strains of genotype G, Bosnia and Herzegovina, December 2010 to September 2012. Euro Surveill. 2014;19:33.
   Google Scholar
• Dittrich S, Hahne S, van Lier A, et al. Assessment of serological evidence for mumps virus infection in vaccinated children. Vaccine. 2015;29(49):9271–9275.
   Google Scholar
• Vandermeulen C, Roelants M, Vermoere M, et al. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine. 2004;22(21–22):2713–2716.
   PubMed Web of Science ®Google Scholar
• Nageswaran P, Jenner L, Paul SP. Resurgence of measles and mumps: not just a childhood problem. Br J Nurs. 2017;26(8):471.
   PubMedGoogle Scholar
• Kontio M, Jokinen S, Paunio M, et al. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis. 2012;206(10):1542–1548.
   PubMed Web of Science ®Google Scholar
• Cardemil CV, Dahl RM, James L, et al. Effectiveness of a third dose of MMR vaccine for mumps outbreak control. New England J Med. 2017;377(10):947–956.
   PubMed Web of Science ®Google Scholar